Evidence map›Paper›PMID 30446431›Full record

ReviewEpidemics2019

Fogarty International Center collaborative networks in infectious disease modeling: Lessons learnt in research and capacity building.

Martha I Nelson, James O Lloyd-Smith, Lone Simonsen, Andrew Rambaut, Edward C Holmes, Gerardo Chowell, Mark A Miller, David J Spiro, Bryan Grenfell, Cécile Viboud

Open access · goldAbstract readReview
In one paragraph

Review in Epidemics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 42 citations in OpenAlex.

  1. Impacts of Responsible Conduct of Research Education on the Career and Practice of Graduating Fellows.Journal of empirical research on human research ethics : JERHRE · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Global Health Perspectives on Race in Research: Neocolonial Extraction and Local Marginalization.International journal of environmental research and public health · 2023
    Review
  7. Article
  8. Article
  9. Biodefence research two decades on: worth the investment?The Lancet. Infectious diseases · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 5 countries.

Martha I NelsonDivision of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda MD, USA.
James O Lloyd-SmithDivision of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda MD, USA; Department of Ecology & Evolutionary Biology, University of California, Los Angeles CA, USA.
Lone SimonsenDepartment of Science and Environment, Roskilde University, Roskilde, Denmark.
Andrew RambautDivision of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda MD, USA; Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, Scotland.
Edward C HolmesMarie Bashir Institute for Infectious Diseases and Biosecurity, Charles Perkins Centre, School of Life and Environmental Sciences and Sydney Medical School, The University of Sydney, Sydney NSW, Australia.
Gerardo ChowellDivision of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda MD, USA; Department of Population Health Sciences, School of Public Health, Georgia State University, Atlanta GA, USA.
Mark A MillerDivision of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda MD, USA.
David J SpiroDivision of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda MD, USA.
Bryan GrenfellDivision of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda MD, USA; Department of Ecology and Evolutionary Biology, Princeton University, Princeton NJ, USA.
Cécile ViboudDivision of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda MD, USA. Electronic address: viboudc@mail.nih.gov.
National Institutes of Health · USRoskilde University · DKThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to a combination of ecological, political, and demographic factors, the emergence of novel pathogens has been increasingly observed in animals and humans in recent decades. Enhancing global capacity to study and interpret infectious disease surveillance data, and to develop data-driven computational models to guide policy, represents one of the most cost-effective, and yet overlooked, ways to prepare for the next pandemic. Epidemiological and behavioral data from recent pandemics and historic scourges have provided rich opportunities for validation of computational models, while new sequencing technologies and the 'big data' revolution present new tools for studying the epidemiology of outbreaks in real time. For the past two decades, the Division of International Epidemiology and Population Studies (DIEPS) of the NIH Fogarty International Center has spearheaded two synergistic programs to better understand and devise control strategies for global infectious disease threats. The Multinational Influenza Seasonal Mortality Study (MISMS) has strengthened global capacity to study the epidemiology and evolutionary dynamics of influenza viruses in 80 countries by organizing international research activities and training workshops. The Research and Policy in Infectious Disease Dynamics (RAPIDD) program and its precursor activities has established a network of global experts in infectious disease modeling operating at the research-policy interface, with collaborators in 78 countries. These activities have provided evidence-based recommendations for disease control, including during large-scale outbreaks of pandemic influenza, Ebola and Zika virus. Together, these programs have coordinated international collaborative networks to advance the study of emerging disease threats and the field of computational epidemic modeling. A global community of researchers and policy-makers have used the tools and trainings developed by these programs to interpret infectious disease patterns in their countries, understand modeling concepts, and inform control policies. Here we reflect on the scientific achievements and lessons learnt from these programs (h-index = 106 for RAPIDD and 79 for MISMS), including the identification of outstanding researchers and fellows; funding flexibility for timely research workshops and working groups (particularly relative to more traditional investigator-based grant programs); emphasis on group activities such as large-scale modeling reviews, model comparisons, forecasting challenges and special journal issues; strong quality control with a light touch on outputs; and prominence of training, data-sharing, and joint publications.

Indexed as

International CooperationAnimalsBirdsCapacity BuildingCommunicable DiseasesHumansInfluenza, HumanInfluenza in BirdsInfluenza VaccinesPandemicsInfluenza VaccinesCapacity buildingComputational modelsControlEmerging disease threatsInfectious diseasesInfluenzaPathogen evolutionPolicyTransmission models

Identifiers

PMID30446431
PMCPMC7105018
OpenAlexW2897303601

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.